Showing results (511-520 of 797) with videos related to

Sort By:
Pageof 80
Scientific Reports|January 3, 2024
Subregion and sex differences in ethanol activation of cholinergic and glutamatergic cells in the mesopontine tegmentumS M Mulloy, E M Aback, R Gao, et al.
Cancer Epidemiology|May 6, 2016
Obesity, diabetes, serum glucose, and risk of primary liver cancer by birth cohort, race/ethnicity, and sex: Multiphasic health checkup studyJessica L Petrick, Neal D Freedman, Jane Demuth, et al.
Diabetes Care|August 28, 2015
Safety and Efficacy of Omarigliptin (MK-3102), a Novel Once-Weekly DPP-4 Inhibitor for the Treatment of Patients With Type 2 DiabetesWayne H-H Sheu, Ira Gantz, Menghui Chen, et al.
Nature Communications|October 19, 2017
Mapping the ultrafast flow of harvested solar energy in living photosynthetic cellsPeter D Dahlberg, Po-Chieh Ting, Sara C Massey, et al.
Diabetes, Obesity & Metabolism|July 19, 2018
A randomized clinical trial of the efficacy and safety of sitagliptin compared with dapagliflozin in patients with type 2 diabetes mellitus and mild renal insufficiency: The CompoSIT-R studyRussell Scott, Jerry Morgan, Zachary Zimmer, et al.
Environmental Health Perspectives|April 23, 2019
Environmental Styrene Exposure and Sensory and Motor Function in Gulf Coast ResidentsEmily J Werder, Dale P Sandler, David B Richardson, et al.
Environmental Health Perspectives|February 23, 2018
Associations between Personal Care Product Use Patterns and Breast Cancer Risk among White and Black Women in the Sister StudyKyla W Taylor, Melissa A Troester, Amy H Herring, et al.
Diabetes, Obesity & Metabolism|July 27, 2012
Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer riskK G Brodovicz, T D Kou, C M Alexander, et al.
Proceedings. Biological Sciences|June 11, 2025
Specialized bark-gnawing beetles reveal phragmotic defence and subcortical ecology in the CretaceousYan-Da Li, Richard A B Leschen, Jiří Kolibáč, et al.
Cardiovascular Diabetology|September 13, 2017
A randomized, placebo-controlled study of the cardiovascular safety of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitusIra Gantz, Menghui Chen, Shailaja Suryawanshi, et al.
Pageof 80